跳至主要内容
临床试验/IRCT2015010711392N2
IRCT2015010711392N2已完成未知

Comparison between efficacy and adverse effects of Ursodeoxy cholic acid, silymarin and vitamin E and placebo (Folic acid) in Anticonvulsive drugs induced hypertransaminasemia in 4 months to 13 years old patients

Vice-chancellor for research-Medical school of Tehran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
4 months 至 13 years(—)
性别
All

入选标准

  • Patients with age between 4 months to 13 years in pediatric neurology ward and clinic of Valiasr hospital with anticonvulsive induced hypertransaminasemia after rule out of common causes of hepatitis such as viral, autoimmune, metabolic and after rule out of anatomical defects have been included. Any patient without parents consent was excluded and any patient with spontaneous decline in transaminases were excluded too.

排除标准

  • 未提供

研究者

发起方
Vice-chancellor for research-Medical school of Tehran University of Medical Sciences

相似试验